Mgc Pharmaceuticals Share Discussion Threads

[sloppyjoe2] 10/4/2024 20:55

Driven your company into the ground? Failed to deliver a single one of the promises made to shareholders? Out of money and investor sentiment? Need a new flock of gullible sheep to fleece? Simples - just change your name and start over. Rinse and repeat...

[cal57] 05/4/2024 16:35

Well I'm sure the name change will solve all the companies problems and create value for all shareholders FFS

[looneytune] 03/4/2024 10:22

No doubt the change of name to comply with LSE rules

[kenbos] 03/4/2024 10:12

What is these suspension about ?

[heatseek77] 21/3/2024 10:24

Argent Biopharma Ltd it is then...

[heatseek77] 21/3/2024 10:22

Tbh graft polymer separate entity

[aimscam1] 15/3/2024 13:12

FRAUDSTER WOW GET IUT WHILE YIU CAN MUST BE WORTH ABOUT 00000001p old money lol . LSE should be sued Roby Zomer, outgoing Chairman, commented: "The shocking conflicts taking place in the Middle East, Ukraine and the Red Sea have had a major impact on the Company and conspired to undermine our business development plans. With the severe constraints on our ability to trade, our financial position has become parlous, forcing the Company to undertake an urgent review of its future direction. "We thank Nicholas and the other lender for providing us with interim working capital. Nicholas's priority as the incoming Chairman is to establish sources of additional funding whilst working with the board to consider the best future for Graft Polymer."

[aimscam1] 15/3/2024 13:10

I WOULD GET OUT WHILE YOU CAN THIS IS GOJNG SAME WAY . Total Fraudster and scum . Had 100 million from this company since 2016 which started in Australia GFG called this correct . Roby Zomer, outgoing Chairman, commented: "The shocking conflicts taking place in the Middle East, Ukraine and the Red Sea have had a major impact on the Company and conspired to undermine our business development plans. With the severe constraints on our ability to trade, our financial position has become parlous, forcing the Company to undertake an urgent review of its future direction. "We thank Nicholas and the other lender for providing us with interim working capital. Nicholas's priority as the incoming Chairman is to establish sources of additional funding whilst working with the board to consider the best future for Graft Polymer."

[blackhorse23] 14/2/2024 08:25

Profit moving to APH

[sloppyjoe2] 13/2/2024 10:18

The CEO may or may not be corrupt, but I fail to see what his religion has to do with anything.

[kenbos] 09/2/2024 19:07

Have to agree with you

[kenbos] 01/2/2024 14:13

Even the mms are struggling to move this can't believe I bought some of these but I did glad it was only a small punt

[blue377] 31/1/2024 07:52

Why has there latest update got a chart from 2021 in it ???

[ic0gcds00] 31/1/2024 07:49

Most corrupt company on aim

[kenbos] 16/1/2024 08:48

Absolutely nothing coming out news wise what happened it was meant to be ready for production and sales were meant to be growing but nothing at all happening my worst investment by a long way oh well ya pays your money and takes ur chances big mistake on this one

[looneytune] 19/12/2023 08:12

Real news:-

MGC Pharmaceuticals Limited ArtemiC(TM) receives FDA Approval in Saudi Arabia
19/12/2023 7:57am
RNS Non-Regulatory

TIDMMXC
MGC Pharmaceuticals Limited
19 December 2023
MGC Pharmaceuticals Ltd.
ArtemiC(TM) receives FDA Approval in Saudi Arabia
19 December 2023
ASX, LSE: MXC
MGC Pharmaceuticals Ltd (MGC Pharma, MGC or the Company), a European based pharmaceutical company specialising in the production and development of innovative medicines for unmet medical needs, is pleased to announce that it has been granted approval for its proprietary product ArtemiC(TM) by the Food and Drug Authority in the Kingdom of Saudi Arabia (Saudi FDA).
Following the success of Phase II clinical trials[1] and European studies on its effectiveness in assisting with the recovery of patients from Covid and long-term Covid, ArtemiC(TM) has now been approved by the Saudi FDA as an over-the-counter (OTC) dietary supplement.
In addition, MGC Pharma appointed specialist consultancy Capital Blossom Ltd in 2022 as its agent to the Kingdom of Saudi Arabia, Sultanate of Oman, United Arab Emirates, Bahrain, Kuwait, and Qatar.
Capital Blossom, through its joint venture collaboration with its Saudi partner have worked on obtaining the approval of the Saudi FDA.
Roby Zomer, CEO and Managing Director of MGC, commented : "We are delighted to receive Saudi FDA approval for ArtemiC(TM) which validates our product and follows the progress we had in USA earlier this year. We are hopeful this will materialise into commercial orders for MGC as we work closely with Capital Blossom Ltd who are specialists in this territory.
About ArtemiC(TM)
ArtemiC(TM) is a clinically tested product. Developed by MGC Pharma, it incorporates GraftBio(R) SNEDD technology, which increases the bioavailability of ArtemiC(TM)'s active ingredients.
In a Phase II double-blind, placebo-controlled Clinical Trial on 50 patients with COVID-19, ArtemiC(TM) demonstrated the following advantages:
-- A full safety and efficacy profile with no drug-adverse events.
-- The ability to prevent deterioration of COVID-19 patients and achieve faster clinical improvement.
-- The ability to reduce symptoms and pain associated with COVID-19.
- Ends-

[kenbos] 18/12/2023 11:42

Another meaningless rns

[ic0gcds00] 12/12/2023 19:18

This company should be thrown off and everybody in it put in jail

[kenbos] 08/12/2023 16:15

Very quiet on here how much has been produced in Malta ?

[tomboyb] 16/11/2023 09:26

40s coming -

[tomboyb] 15/11/2023 15:54

Indeed -

Patience is a virtue -

[marvelman] 15/11/2023 15:52

Bought in last week having followed this for what seems an eternity. Money troubles out of the way for a little while now allowing them to concentrate on selling the story and growing the take up. Its been a horrendous time foe those who had stuck with it but for those still remaining this is surely a turning point.

[tomboyb] 15/11/2023 09:48

Virtually no stock -